Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer's Disease

被引:11
|
作者
Bertrand, Elodie [1 ]
van Duinkerken, Eelco [1 ,2 ,3 ]
Landeira-Fernandez, J. [1 ]
Dourado, Marcia C. N. [4 ]
Santos, Raquel L. [4 ]
Laks, Jerson [4 ,5 ]
Mograbi, Daniel C. [1 ,6 ]
机构
[1] Pontificia Univ Catolic Rio PUC Rio, Dept Psychol, Rio De Janeiro, Brazil
[2] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Diabet Ctr, Dept Internal Med, Amsterdam, Netherlands
[4] Fed Univ Rio de Janeiro UFRJ, Ctr Alzheimers Dis, Inst Psychiat, Rio De Janeiro, Brazil
[5] Univ Grande Rio Unigranrio, Post Grad Program Translat Biomed, Caxias, Brazil
[6] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England
来源
关键词
BPSD; clinical capacity; decision making; consent to treatment; dementia; Alzheimer's disease; DECISION-MAKING CAPACITY; MILD COGNITIVE IMPAIRMENT; MACARTHUR TREATMENT COMPETENCE; NEUROPSYCHIATRIC-INVENTORY; EXECUTIVE FUNCTION; MENTAL-CAPACITY; CONSENT; DEMENTIA; ANOSOGNOSIA; VERSION;
D O I
10.3389/fnagi.2017.00182
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Decision-making is considered a fundamental aspect of personal autonomy and can be affected in psychiatric and neurologic diseases. It has been shown that cognitive deficits in dementia impact negatively on decision-making. Moreover, studies highlighted impaired clinical competence in neuropsychiatric disorders, such as schizophrenia and bipolar disorder. In this context, the current study explored the relationship between behavioral and psychological symptoms of dementia (BPSD) and clinical competence, especially the capacity to consent to treatment, in Alzheimer's disease (AD). Seventy-one patients with mild to moderate AD participated, completing assessments for capacity to consent to treatment, general cognition and neuropsychiatric disturbances. For each neuropsychiatric symptom, patients with and without the particular disturbance were compared on the different subscales of the MacArthur Competence Tool for Treatment (MacCAT-T; Understanding, Appreciation, Reasoning and Expression). The results showed that patients presenting delusions, as well as apathetic patients, had a lower ability to express a clear treatment choice compared to patients without these symptoms. By contrast, patients with dysphoria/ depression had higher scores on this variable. Additionally, AD patients with euphoria had more difficulties discussing consequences of treatment alternatives compared to patients without this disturbance. None of the differences were confounded by global cognition. There were no between-group differences in clinical decision-making for patients with hallucinations, agitation/aggression, anxiety, irritability, disinhibition and aberrant motor behavior. These findings highlight the importance of taking BPSD into account when assessing decision-making capacity, especially clinical competence, in AD. Furthermore, reducing BPSD may lead to better clinical competence in patients with AD, as well as to improvements in patients and caregivers' quality of life.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Impact of behavioral and psychological symptoms of Alzheimer’s disease on caregiver outcomes
    Kanokporn Pinyopornpanish
    Atiwat Soontornpun
    Tinakon Wongpakaran
    Nahathai Wongpakaran
    Surat Tanprawate
    Kanokwan Pinyopornpanish
    Angkana Nadsasarn
    Manee Pinyopornpanish
    Scientific Reports, 12
  • [2] Impact of behavioral and psychological symptoms of Alzheimer's disease on caregiver outcomes
    Pinyopornpanish, Kanokporn
    Soontornpun, Atiwat
    Wongpakaran, Tinakon
    Wongpakaran, Nahathai
    Tanprawate, Surat
    Pinyopornpanish, Kanokwan
    Nadsasarn, Angkana
    Pinyopornpanish, Manee
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] Behavioral and Psychological Symptoms in Alzheimer's Disease
    Li, Xiao-Ling
    Hu, Nan
    Tan, Meng-Shan
    Yu, Jin-Tai
    Tan, Lan
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [4] Behavioral and psychological symptoms of Alzheimer's disease
    Sawsan, D.
    Farhat, N.
    Zouari, L.
    Omri, S.
    Dammak, M.
    Maalej, M.
    Mhiri, C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 777 - 777
  • [5] Impact of donepezil and memantine on behavioral and psychological symptoms in patients with Alzheimer's disease
    Rozankovic, P. Bago
    Badzak, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 580 - 580
  • [6] Treatment of Behavioral and Psychological Symptoms of Alzheimer’s Disease
    Anne Corbett
    Jessica Smith
    Byron Creese
    Clive Ballard
    Current Treatment Options in Neurology, 2012, 14 : 113 - 125
  • [7] Treatment of Behavioral and Psychological Symptoms of Alzheimer's Disease
    Corbett, Anne
    Smith, Jessica
    Creese, Byron
    Ballard, Clive
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (02) : 113 - 125
  • [8] Behavioral and psychological symptoms in the preclinical stage of Alzheimer's disease
    Bidzan, Leszek
    Pachalska, Maria
    Grochmal-Bach, Bozena
    Bidzan, Mariola
    Cieslukowska, Anna
    Pufal, Anna
    MEDICAL SCIENCE MONITOR, 2008, 14 (09): : CR473 - CR479
  • [9] The pharmacological treatment of behavioral and psychological symptoms of Alzheimer's disease
    Alexopoulos, P.
    Gourzis, P.
    ARCHIVES OF HELLENIC MEDICINE, 2008, 25 (06): : 707 - 719
  • [10] Behavioral and psychological symptoms in the preclinical stage of Alzheimer's disease
    Pachalska, Maria
    MEDICAL SCIENCE MONITOR, 2008, 14 (10): : LE16 - LE17